Budesonide

• CAT Number: A000237
• CAS Number: 51333-22-3
• Molecular Formula: C25H34O6
• Molecular Weight: 430.53
• Purity: ≥95%
• Synonyms: Budesonide;Budesomide
• Target: Glucocorticoid Receptor
• Solubility: >20.2mg/mL in DMSO
• Storage: Store at -20C
• IUPAC Name: (1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one
• InChI: InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1
• InChIKey: VOVIALXJUBGFJZ-KWVAZRHASA-N
• SMILES: CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C

Budesonide（Cat No.:A000237）is a potent corticosteroid used to treat respiratory and gastrointestinal conditions. It effectively manages asthma, chronic obstructive pulmonary disease (COPD), and Crohn’s disease by reducing inflammation and suppressing immune responses. With a high topical anti-inflammatory activity and minimal systemic effects, Budesonide is available in inhalers, nasal sprays, and oral forms. Its targeted delivery system ensures effective relief with reduced side effects, making it ideal for long-term management of chronic conditions. This versatile medication improves patients’ quality of life through its efficient and focused therapeutic action.